Radiology has experienced exponential growth with regard to helical multi-slice CT scanning using multiple-row detector arrays for the simultaneous collection of data at different slice locations, allowing rapid acquisition of large datasets of longitudinal volumes. The optimal MRI field strength in general clinical practice is 1.5 tesla (T), while 3 T allows mapping of cerebral cortical function by utilising blood oxygen level-dependent (BOLD) imaging. In vivo spectroscopy monitors neuronal viability, cell membrane proliferation and energy metabolism. Current clinical 3 T products have been developed to fit within the physical constraints of 1.5 T platforms by using compact magnets with small fringe fields. Magnets with field strengths of 7 T and even higher are in experimental use. [1] An important in uence on medical imaging since the beginning of the 21st century has been the increasing availability of hybrid imaging systems. ese systems enable a more integrated approach, and de ne the unitary entity of diagnostic clinical imaging sciences. e concept of hybrid imaging is simple -PET or a single photon emission computed tomography (SPECT) scanner is integrated with a CT scanner on a single platform.
e patient is examined using both techniques in immediate succession without any positional changes. Images are fused and displayed by dedicated so ware. Detailed anatomical imaging combined with the high sensitivity of functional information provides much more information than would be provided by the two individual techniques. e composite images are also generally better appreciated by clinicians.
CT scanners on integrated platforms are mostly high-quality multi-slice diagnostic units. Adding contrast enhancement a ords the potential for performing a single comprehensive diagnostic study. PET/MRI, a recent development, is currently being clinically evaluated.
This article highlights clinical scenarios where radiology and nuclear medicine are combined to address speci c clinical problems. An exhaustive list of these problems is inapplicable, as unique diagnostic dilemmas continually occur. In our experience, these are best addressed by continuous interaction and regular interdisciplinary meetings.
Oncology
Due to its high sensitivity, PET -using the glucose analogue [F-18] ourodeoxyglucose (FDG) -is transforming the diagnosis and management of many malignancies. Integrated PET/CT studies enhance both accuracy and logistic e ciency. Abnormal FDG uptake helps the radiologist to scrutinise areas of subtle anatomical changes, o en increasing speci city (Fig. 1) . CT also enhances speci city by localising FDG uptake to physiological sites, such as brown fat, which on PET alone can mimic nodal disease. Similarly, the limitations inherent in the ability of FDG-PET to distinguish a neoplasm from in ammation are sometimes improved by CT patterns that are more suggestive of either in ammation or a tumour. PET generally has excellent sensitivity, while CT detects small lung nodules more accurately.
Size-based lymph node evaluation for metastatic involvement (short axis >10 mm) and morphology has a low sensitivity and specificity. FDG-PET frequently demonstrates small nodes that are not benign and large nodes that are not metastatic (Fig. 1) . FDG uptake has the ability to distinguish residual tumour activity from scar tissue in residual masses a er chemotherapy. [2] Neuro-endocrine tumours An integrated approach is essential in the assessment of neuro-endocrine tumours (NETs). The final diagnostic analysis combines functional, morphological and positional information. A detailed radiological work-up is only possible once a functional lesion has been localised. Localisation of well-di erentiated NETs is performed by using labelled analogues of somatostatin, or molecules concentrated by NETs. [3] Staging and planning of targeted radiotherapy require functional techniques, while anatomical imaging is important for monitoring disease and planning of surgery (Fig. 2) .
Musculoskeletal imaging
Bone scintigraphy is a rst-line technique for surveying the entire skeleton for metastases in patients with cancer of the breast Imaging has seen greater integration of modalities, de ning the entity of diagnostic clinical imaging sciences.
and prostate, as well as small-cell lung carcinoma. While highly sensitive, the speci city is reduced by numerous benign processes (e.g. degenerative changes, old trauma). Here, radiology has a longestablished complementary role, as local radiographs of these sites identify most benign causes of increased activity, whereas normal radiographs are suggestive of metastatic disease.
e sensitivity of MRI depends on focal loss of the T1 signal due to metastatic replacement/destruction of marrow fat cells in trabecular bone. T1 changes appear up to three months before other modalities are positive; [4] however, MRI studies are limited by cost and a small eld of view, disqualifying it as a viable screening alternative to bone scintigraphy. T1-weighted MRI sequences should be reserved for speci c clinical problems, e.g. breast carcinoma with persistent lower back pain, and equivocal focal activity on a bone scan not resolved with plain radiographs. Di usion-weighted whole-body MRI is 
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an exciting new development with promising results for cancer detection, widely reported in the recent literature. [5] w Bone scintigraphy plays a complementary role in benign bone disease, adding sensitivity and enabling an entire skeletal survey. Most fractures are diagnosed using conventional radiographs, but bone scanning is a cost-e ective and sensitive means of detecting fractures, which have a normal appearance on plain lms (e.g. undisplaced, di cult sites) and insu ciency/stress fractures. Scintigraphy also allows localisation of sites causing back, ankle or foot pain. When there are subtle or multiple anatomical abnormalities, active osteoblastic activity can direct therapeutic interventions to sites requiring relief of pain (Fig. 3) .
Acute osteitis in children can present challenging diagnostic dilemmas. ese children o en present as emergency cases, acutely ill and with raised in ammatory markers. e presenting complaint may, however, be limited to di use bone pain with normal erythrocyte sedimentation rate (ESR) and white blood cell (WBC) counts. Plain lm examination of the a ected limb should precede special investigations. Ultrasound is an excellent rst-line investigation and 
is o en diagnostic (Fig. 4) . CT is an acceptable alternative, but an MRI study, when available, is de nitive, showing the extent of trabecular oedema and so -tissue involvement. Skeletal scintigraphy remains particularly valuable when MRI availability is limited, symptoms are poorly localised, or multifocal disease is suspected. [6] 
Soft-tissue infection
Ultrasound is normally the rst line of investigation, but MRI, with its superior so -tissue discrimination, is the investigation of choice. In ammatory processes are identi ed by a hyperintense signal on T2 STIR or post-contrast T1 fat saturation sequences. However, an altered anatomy because of previous trauma or surgery may render ndings equivocal. In these situations the introduction of infection markers such as labelled WBCs, FDG, and [Ga-67] citrate assist in the evaluation of disease (Fig. 5) . ese tracers are speci c and sensitive, demonstrating in ammatory processes before anatomical changes occur. e choice of technique depends on the suspected site and chronicity of the infection. e role of FDG-PET/CT is still being de ned, but it is likely to become important in many of these clinical scenarios. [7] Pulmonary embolism e imaging of acute pulmonary embolism has advanced with the widespread implementation of CT pulmonary angiography (CTPA) and the emerging role of ventilation perfusion (VQ) SPECT (VQS). CTPA is based on the direct detection of emboli presenting as lling defects in a ected vessels, while VQS images the functional consequences of the emboli, i.e. underperfused lung segments (Fig. 6) . VQS, using new interpretation criteria, achieves excellent sensitivity and speci city with few equivocal studies, and today should be utilised by all nuclear medicine units. [8] Comparative literature is limited, complicated by the lack of a gold standard, and confused by comparisons of CTPA with older planar VQ studies.
Both CTPA and VQS are excellent rst-line investigations and their availability o en determines the rst choice. Speci c considerations such as compromised cardiorespiratory function or structural lung disease favour the use of CTPA when both modalities are available. Similarly, a mosaic perfusion pattern in the appropriate clinical setting on high-resolution CT scans is diagnostic for chronic pulmonary embolism as a cause of unexplained pulmonary hypertension. Conversely, VQS has a signi cantly lower radiation dose, making its use preferable in pregnancy, in patients with impaired renal function, and in patients in whom prior reactions to contrast media are suspected. Perhaps, most importantly, performing the other examination is useful in those cases where one modality is initially equivocal or discordant with the clinical setting.
Acute cholecystitis
Ultrasound is the initial imaging technique of choice in patients with suspected acute cholecystitis. is is justi ed in light of its widespread availability and e cacy in the majority of patients. In cases where ultrasound is di cult to interpret (e.g. technically di cult examinations, acalculous disease), hepatobiliary scintigraphy has a An integrated approach is essential in the assessment of neuro-endocrine tumours (NETS).
Fig. 9. Bilateral hydronephnosis on CT (A). e renogram shows no obstruction of the le kidney, with normal function and a good response to furosemide at 20 minutes (B)
. e right kidney has a di erential function of only 14% due to obstructive nephropathy. 
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high sensitivity and speci city, [9] making it an appropriate second-line investigation when clinical suspicion is high.
Liver lesions
Functional imaging with characteristic scintigraphic patterns can assist with the identi cation of liver lesions detected on anatomical imaging (Fig. 7) . In liver lesions equivocal for metastatic disease, increased uptake of FDG on PET/CT distinguishes metastatic disease from benign lesions. Increased Tc-99m colloid uptake in a liver lesion is speci c for focal nodular hyperplasia. Haemangiomas show enhancement of Tc99m-labelled red blood cells. Developments in MRI liver contrast media have resulted in substances that mirror the biodistribution patterns of radionuclide tracers. Gadolinium chelates are distributed to the interstitial space, ferumoxides are taken up by Kup er cells, and the new mangafodiper agents create T1 shortening a er hepatocyte uptake via the B 6 receptor. Exquisite anatomical detail is an added advantage, but this has signi cant nancial implications.
Residual splenic tissue
Patients with resistant idiopathic thrombocytopenic purpura, despite splenectomy, often have continued destruction of platelets by small amounts of residual splenic tissue. This tissue is frequently difficult to detect using anatomical imaging alone. SPECT/CT using Tc-99m-labelled damaged red blood cells is sensitive and speci c for splenic tissue (Fig. 8) , allowing lesions to be located and guiding their surgical removal.
Renal imaging
Ultrasound plays an essential role in many types of renal disease. e combination of ultrasound and other anatomical modalities with functional imaging is particularly rewarding in the renal system. Diuresis renography using Tc-99m MAG-3 clari es the significance of hydronephrosis and/ or hydro-ureter. Obstructive nephropathy can be ruled out in patients with a normal diuretic response, while reduced di erential renal function, especially on serial studies, points to the need for intervention (Fig. 9 ).
e distinction between renal artery stenosis and renal vascular hypertension explains the di erent roles of angiography and captopril renography in the management of these patients. While anatomical imaging is essential for the detection and sometimes for the treatment of stenotic arterial lesions, captopril renography determines the functional signi cance of lesions, predicts the outcome of interventions, and detects renovascular hypertension related to microvascular disease.
Radiology and nuclear medicine have overlapping roles in the imaging of renal scarring and vesico-ureteric re ux (VUR) in children. A first-time urinary tract infection (UTI) requires ultrasound, which, if normal, obviates the need for further imaging. Children with recurrent UTIs or abnormalities on ultrasound normally require a variety of possible investigations. [10] Dimercaptosuccinic acid (DMSA) renal scintigraphy is the most sensitive widely available technique to detect renal scarring. For VUR, a micturating cysto-urethrogram (MCUG) provides important anatomical information, while indirect cystography is a well-tolerated procedure which has a low radiation dose.
Incidental renal masses are being increasingly identi ed on advanced imaging modalities, more so with present-generation multi-slice CT scanners. A renal pseudotumour due to a prominent column of Bertin shows uptake of Tc-99m DMSA, while renal tumours show no uptake. [11] 
Interventional radiology
The interventional radiologist may be assisted by functional imaging. e choice of an optimal site for taking a biopsy is o en facilitated by PET/CT, revealing active disease processes in more accessible sites. Similarly, the use of metabolic information can reduce sampling errors.
Managing gastrointestinal bleeding is challenging when endoscopy is negative, or difficult to interpret owing to large amounts of intraluminal blood. Angiography and embolisation of bleeding sites can be assisted by localisation of gastrointestinal bleeding sites using Tc-99m-labelled red blood cells (Fig. 10) . Even localisation limited to the major artery involved prior to angiography can assist with catheter placement.
The growing utilisation of targeted radiotherapy for palliation of inoperable liver lesions requires close collaboration between the interventional radiologist, who places the catheter in the hepatic artery, and the nuclear medicine physician, who administers the therapy, a er scintigraphically con rming correct positioning.
Conclusions
Taking a complementary rather than an exclusive approach allows for the optimal utilisation of the diverse spectrum of imaging technologies available. This philosophy is being practised increasingly with the advent of hybrid imaging, and the resulting interdependence of these disciplines. A good understanding of the strengths and weaknesses of the di erent modalities available is needed to achieve this goal. It is the duty of imaging specialists to develop approaches to clinical problems that are better integrated, provide improved care, diagnostic accuracy, and 
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cost-e ectiveness. e optimal utilisation of all imaging modalities, including their complementary strengths, di ering availability, and cost considerations, is arguably the single most important challenge to all diagnostic imaging clinicians.
